(updated to add analyst comment)Argus downgraded Gilead Sciences (NASDAQ: GILD) from Buy to Hold.Analyst David Toung steps ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE